# Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

> **NCT01244425** · PHASE2 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 70 (actual)

## Conditions studied

- Bleeding (Oozing) in Hepatic Resection

## Interventions

- **DRUG:** Fibrin Sealant (FS) VH S/D 500 s-apr
- **OTHER:** Manual compression

## Key facts

- **NCT ID:** NCT01244425
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2013-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244425, "Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01244425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*